Central Asia Region Country Profile

Central Asia Regional Profile

Discover more about CDC’s work in the Central Asia Region by
viewing our detailed country profileCdc-pdf

Country Overview

CDC’s Central Asia Regional office was established at the U.S. Consulate in Almaty, Kazakhstan in 1995 but expanded its operations ten years later when it began directly receiving funds through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to strengthen national public health programs focused on HIV and tuberculosis (TB). Through PEPFAR, CDC continues to work with the governments of the Central Asia Region (primarily Kazakhstan, Kyrgyzstan, and Tajikistan) to accelerate their progress toward achieving HIV epidemic control. CDC supports the use of high-quality epidemiological data to develop and scale up high-impact HIV prevention and treatment services that reach key populations (particularly persons who inject drugs) in high-burden regions. CDC also provides direct financial and technical assistance to Republican AIDS Centers and Republican Narcological Centers in all three countries, which supports these government organizations to develop and execute evidence-based strategies and guidelines for HIV-infection control.

$8,800

Per Capita GNI (2016)

17.8 (2016)

Population (million)

11 (2016) Live Births (2016)

Under 5 Mortality

72 years (2016)

Life Expectancy

(Ages 15-49): 0.2% (2017)

Estimated HIV Prevalence

<1,000 (2017)

Estimated AIDS Deaths

4,500 (2017)

Estimated Adults and Children living with HIV

11,037 (2017)

Reported Number Receiving Antiretroviral Therapy (ART)

67 (2016)

Estimated TB Incidence

5% (2016)

TB patients with known HIV-status who are HIV-positive

91% (2016)

Treatment Success Rate

$1,110

Per Capita GNI (2016)

6.08 (2016)

Population (million)

21 (2016) Live Births

Under 5 Mortality

71 years (2016)

Life Expectancy

(Ages 15-49): 0.2% (2017)

Estimated HIV Prevalence

<200 (2017)

Estimated AIDS Deaths

1,600 (2017)

Estimated Adults and Children living with HIV

2,792 (2016)

Reported Number Receiving Antiretroviral Therapy (ART)

145 (2016)

Estimated TB Incidence

3% (2016)

TB patients with known HIV-status who are HIV-positive

82% (2015)

TB Treatment Success Rate

$1,110

Per Capita GNI (2016)

8.73 (2016)

Population (million)

43 (2016) Live Births

Under 5 Mortality

71 years (2016)

Life Expectancy

(Ages 15-49): 0.3% (2017)

Estimated HIV Prevalence

<1,000 (2017)

Estimated AIDS Deaths

6,300 (2017)

Estimated Adults and Children living with HIV

4,275 (2017)

Reported Number Receiving Antiretroviral Therapy (ART)

85 (2016)

Estimated TB Incidence

3% (2016)

TB patients with known HIV-status who are HIV-positive

89% (2015)

TB Treatment Success Rate

$2,220

Per Capita GNI (2016)

31.85 (2016)

Population (million)

24 (2016) Live Births

Under 5 Mortality

71 years (2016)

Life Expectancy

(Ages 15-49): 0.3% (2017)

Estimated HIV Prevalence

1,900 (2017)

Estimated AIDS Deaths

14,745 (2017)

Reported Number Receiving Antiretroviral Therapy (ART)

76 (2016)

Estimated TB Incidence

4% (2016)

TB patients with known HIV-status who are HIV-positive

89% (2015)

TB Treatment Success Rate


Strategic Focus

Strengthening Public Health Systems

HIV Services: CDC supports the provision of technical assistance for the implementation of Test and Treat in nine model health facilities providing high quality HIV, Tuberculosis (TB) and diagnostic laboratory services in Luanda to showcase best practices, and replicate throughout the country.

Field Epidemiology Training Program (FETP): CDC provides support to improve HIV disease surveillance, data quality collection, analysis and to build capacity for effective outbreak alert and response through providing support to the FETP.

Strengthening Laboratory Systems and Networks
CDC builds laboratory capacity, including diagnostic services for HIV and Tuberculosis (TB) and quality management systems. CDC supports laboratory strengthening through providing technical assistance and mentorship training on viral load (VL) monitoring, use of GeneXpert for point of care VL, early infant diagnosis (EID) and TB diagnostics at the model facilities. CDC supports laboratory accreditation process for two labs including the National TB reference lab and the National AIDS Program lab.

Strengthening Health Information Systems
Working closely with the National Aids Program and National TB Program, CDC provides support for the development and implementation of health information systems. CDC supports the use of a longitudinal electronic information system at the 9 model health facilities to effectively track individual patients through the continuum of treatment from HIV diagnosis and antiretroviral treatment (ART) initiation to pharmacy pick-up and VL monitoring.

Key Activities and Accomplishments

• Scale up of successful high-yield HIV testing modalities, including facility and community index testing, and identification and HIV testing of presumptive TB patients.

• MOHW’s universal ART treatment strategy, initiated in June, 2016, aims to provide antiretroviral treatment to all. CDC provides technical assistance to improve clinical services and ensure evidence-based modalities are implemented to enhance treatment initiation, adherence and retention for people living with HIV (PLHIV).

• The PMTCT program is one of Botswana’s success stories. It was grounded in CDC’s research findings. Now, CDC’s technical assistance provides training, mentoring and strengthening of existing clinical systems to support pregnant HIV-positive mothers and their HIV-exposed babies.

• Cervical cancer technical assistance is aimed to support the MOHW to scale up capacity in preventing cervical cancer in PLHIV. Capacity building includes policy development, training, and mentorship.

• The national Safe Male Circumcision (SMC) program was launched 2009. CDC supports the SMC program through technical assistance, service delivery, and demand creation.

• CDC strengthens the MOHW’s data systems and use by providing expertise and technical assistance to enhance data completeness and quality, improve surveillance systems, and increase data use.

• In collaboration with the MOHW and PEPFAR, CDC provided technical assistance for the construction and equipping of the National Public Health Laboratory (NPHL). The NPHL was built to establish laboratory capacity for routine surveillance and response to public health emergencies; to improve the availability, quality, and use of laboratory data for evidence-based decision making and planning in support of routine surveillance and epidemiologic investigations; and to foster collaboration between human, animal and environmental health laboratories. The NPHL hopes to provide a forum to promote partnerships as Botswana strives for a One Health approach to healthcare.

• Results from CDC’s BCPP study led to innovative testing, linkage to treatment, and retention strategies. Lessons learned in heath information system challenges, poor documentation of viral load testing, and other key operational and research questions have been rapidly translated into programs for maximum impact.


Social Media CardCdc-image

CDC’s innovative efforts to Find, Cure, and Prevent TB are creating a safer America and a safer world.

Cdc-image

Social Media CardCdc-image

TB is the #1 killer of people living with HIV. TB preventative treatment protects those with HIV from contracting TB Disease. It’s effective, It’s affordable. It saves lives.

Cdc-image

Social Media CardCdc-image

CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries.

Cdc-image

Page last reviewed: September 24, 2018, 01:10 PM